The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
NGS testing for patient selection in left-sided RAS/BRAF wild-type metastatic colorectal cancer receiving anti-EGFR therapy.
 
Tatiana Antonova
No Relationships to Disclose
 
Ilya Pokataev
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Eisai; Merck; Novartis; Pfizer; Pierre Fabre; Roche; Swixx BioPharma
 
Olesia Stativko
No Relationships to Disclose
 
Margarita Nosova
No Relationships to Disclose
 
Maria Byachova
No Relationships to Disclose
 
Mikhail Fedyanin
No Relationships to Disclose
 
Alexey Tryakin
Stock and Other Ownership Interests - Amgen; Bayer; Lilly; Merck; Merck Serono
Consulting or Advisory Role - Amgen; AstraZeneca; BioCad; Bristol-Myers Squibb; Eisai; Lilly; Merck Sharp & Dohme; Roche/Genentech
Speakers' Bureau - Amgen; AstraZeneca/Daiichi Sankyo; Bayer; Bayer Health; BioCad; Bristol-Myers Squibb; Eisai; Lilly; Merck Serono; Merck Sharp & Dohme; Novartis; Pfizer; Sanofi
Research Funding - Biocad (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; BioCad; Merck Serono; Novartis; Sanofi; Veropharm
 
Maxim Ivanov
No Relationships to Disclose
 
Vladislav Mileyko
No Relationships to Disclose
 
Vsevolod Galkin
No Relationships to Disclose